|
|||||
![]() |
|
Nvidia's largest stock holding is CoreWeave, which has more than doubled since its March IPO.
Changes in the prices of Nvidia's stock holdings have had a notable positive effect on its recent earnings.
Nvidia's active investing can also help it identify attractive potential acquisitions.
Nvidia (NASDAQ: NVDA) stock has been a fantastic investment. And there are good reasons to believe that shares of the artificial intelligence (AI) technology infrastructure leader will continue to outperform over the long term.
One benefit of owning Nvidia stock that doesn't get enough coverage: When you buy the stock, you also get part ownership in the company's portfolio of AI-focused stocks, those both publicly traded and privately held. It's akin to owning an AI exchange-traded fund (ETF).
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More »
Nvidia has recently ramped up its investing activity, and its stock holdings are already large enough to move the needle on its overall financial results.
Image source: Getty Images.
The below stocks are listed in order of their value in Nvidia's portfolio as of the end the second quarter. Nvidia is listed at the end for reference.
Company | Core Business | Market Cap | Number of Shares Nvidia Owns / Nvidia's Percentage Stake as of End of Q2* | Value as of End of Q2 | Stock's Year-to-Date 2025 Return |
---|---|---|---|---|---|
CoreWeave (NASDAQ: CRWV) | Operates a graphics processing unit (GPU)-based AI cloud computing platform | $50.3 billion | 24.28 million / 5% | $3.96 billion |
158%** |
Arm Holdings (NASDAQ: ARM) | Leading designer and licensor of central processing units (CPUs) | $146.5 billion | 1.10 million / 0.1% | $178.1 million |
12.1% |
Applied Digital (NASDAQ: APLD) | Builds and operates GPU-based AI data centers | $4.2 billion | 7.72 million / 2.9% | $77.7 million |
109% |
Nebius Group (NASDAQ: NBIS) | Operates a GPU-based AI cloud platform, and has several other operations | $16.3 billion | 1.19 million / 0.5% | $65.9 million |
147% |
Recursion Pharmaceuticals (NASDAQ: RXRX) | Clinical-stage biotech using AI for drug discovery and development | $2.0 billion | 7.71 million / 1.8% | $39.0 million |
(30.5%) |
WeRide (NASDAQ: WRD) | China-based developer of autonomous driving tech and operator of robotaxis | $2.7 billion |
1.74 million / 0.6% |
$13.7 million |
(34%) |
Total | -- | -- | -- | $4.33 billion | -- |
Nvidia | AI tech infrastructure leader, including AI chip (GPU) leader | $4.2 trillion | -- | -- | 29.7% |
S&P 500 | N/A | N/A | N/A | N/A | 10.8% |
Data sources: Nvidia's 13-F SEC filing, Yahoo! Finance, and YCharts. Market cap and stock performance data as of Friday, Aug. 29, 2025. *Calculation by author. **Since initial public offering (IPO) in March 2025.
Are any of the above companies in which Nvidia has a stake profitable?
Most of the companies are not profitable, as most are relatively newly public companies and pouring money into scaling up operations to drive revenue growth.
Arm is the only company that can be considered profitable. For its most recently reported quarter and on a trailing-12-month basis, its net income -- and, hence, "earnings" -- was positive from both a generally accepted accounting principles (GAAP) and adjusted basis.
None of the other companies had positive adjusted net income in their most recently reported quarter. (Nebius had positive GAAP net income but only because of a large accounting gain from "revaluation of investment in equity securities.")
Nvidia has a venture capital arm called NVentures, which focuses on investing in AI-related start-ups during their early funding rounds. NVentures aims to make an eventual profit from its investments, so it can be considered one of Nvidia's potential profit streams.
NVentures was formed in 2021, replacing Nvidia's former VC arm. It has been much more active than the former VC entity, and is led by Mohamed ("Sid") Siddeek, who has an impressive VC background.
NVentures' website lists 27 companies as investments, as of Aug. 29. A major trend is the large number of investments in the healthcare sector (13), and specifically in companies using AI for drug discovery and development (nine).
This makes sense because the total addressable market (TAM) for pharmaceuticals is massive. Estimates by various sources peg it at about $1.7 trillion in 2024. Moreover, discovering and developing new drugs is an extremely costly and lengthy process. AI has the potential to cut those costs and speed up time to market.
In its fiscal second quarter (ended July 27), Nvidia's portfolio of AI-focused investments added about $2.2 billion to its net income. This amounts to about 8.5% of its total quarterly adjusted net income of $25.8 billion.
This $2.2 billion gain was only an accounting gain stemming from price changes in its stock holdings over the quarter. An actual cash gain (or loss) occurs when Nvidia sells an investment in part or in entirety. This accounting gain was helped by a strong market (the S&P 500 was up 15.6% over Nvidia's fiscal Q2). However, the sheer size of this gain suggests Nvidia's investing prowess is very good.
Beyond the obvious potential benefit to Nvidia's profits, the company's active investing, especially in early stage AI start-ups, has a not-so-obvious benefit: It can help Nvidia identify attractive potential acquisitions. Nvidia might like one of its NVentures companies so much that it could decide to buy it.
In short, there are many reasons to buy Nvidia stock. The icing on the cake is that Nvidia stock investors also get a stake in the many publicly traded and privately held AI stocks that Nvidia owns.
Before you buy stock in Nvidia, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Nvidia wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $651,599!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,067,639!*
Now, it’s worth noting Stock Advisor’s total average return is 1,049% — a market-crushing outperformance compared to 185% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.
*Stock Advisor returns as of August 25, 2025
Beth McKenna has positions in Nvidia. The Motley Fool has positions in and recommends Nvidia. The Motley Fool recommends Nebius Group. The Motley Fool has a disclosure policy.
20 min | |
25 min | |
30 min | |
50 min | |
1 hour | |
1 hour | |
1 hour | |
1 hour | |
1 hour | |
1 hour | |
2 hours | |
2 hours |
Stock Market Today: Dow Wavers Ahead Of Key Data; Alphabet, Apple Surge On Court Ruling (Live Coverage)
NVDA
Investor's Business Daily
|
2 hours | |
2 hours | |
2 hours |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite